METHYL(([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YLMETHYL))AMINE, 95.0%, 250mg

5-Hexenoic Acid>98.0%(GC)(T)25g

6-Bromo-2-methylquinazolin-4(3H)-one, 95.0%, 5g

4-Morpholin-4-ylpyridin-2-amine, 97.0%, 1g

Phenoxypolyethylene Glycol Acrylate (n=approx. 2) (stabilized with MEHQ)500g

TERT-BUTYL 3-((METHOXYCARBONYL)METHYL)-1H-INDOLE-1-CARBOXYLATE, 95.0%, 25g

2,2-Bis(4-hydroxy-3-methylphenyl)propane>98.0%(GC)500g

(R)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 250mg

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(1H-imidazol-5-yl)propanoate, 95.0%, 100g

5-(Trifluoromethyl)pyrimidine-2,4(3H,5H)-dione, 95%, 1g

(1R,4R)-tert-Butyl N-[4-(pyrimidin-4-ylamino)cyclohexyl]carbamate, 1g

Methyl 4-chloro-2,6-dimethylbenzoate, 95%, 500mg

1,2-Dichloro-3-methyl-5-nitrobenzene, 97%, 1g